Tamoxifen restrains the growth of BC cells by competitively antagonizing the ER; however, it causes well-documented estrogen-like adverse events in the genital tract, in the hepatic and bone metabolism, and in the coagulative pattern [9]. Here, ESR1 is linked to breast cancer.